Saranya Chumsri, MD, and Adam M. Brufsky, MD, PhD, discuss the evaluation of Bria-IMT plus a checkpoint inhibitor in metastatic breast cancer
Examining the Novelty of Vaccine-Based Therapy in Metastatic Breast Cancer
Adam M. Brufsky, MD, PhD, FACP, discusses the unique design of the allogeneic GM-CSF–secreting breast cancer vaccine SV-BR-1-GM.
Advertisement
Advertisement
Trending on OncLive
1
BI-1808 Shows Efficacy as Monotherapy and in Combination With Pembrolizumab in T-Cell Lymphomas
2
Real-World Mogamulizumab Elicits Durable Responses in Pretreated Mycosis Fungoides and Sézary Syndrome
3
FDA Accepts Third RP1 BLA Resubmission With Nivolumab in Advanced Melanoma
4
CHMP Recommends Pirtobrutinib for EU Approval in CLL Across All Lines of Therapy
5